atrasentan has been researched along with prednisone in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (prednisone) | Trials (prednisone) | Recent Studies (post-2010) (prednisone) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 41,222 | 5,274 | 8,409 |
| Protein | Taxonomy | atrasentan (IC50) | prednisone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 1.146 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.146 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SS; Rumohr, JA | 1 |
1 review(s) available for atrasentan and prednisone
| Article | Year |
|---|---|
Current chemotherapeutic approaches for androgen-independent prostate cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Bevacizumab; Cancer Vaccines; Chemotherapy, Adjuvant; Clinical Trials as Topic; Docetaxel; Endothelin-1; Estramustine; Humans; Male; Mitoxantrone; Prednisone; Prostatic Neoplasms; Pyrrolidines; Randomized Controlled Trials as Topic; Taxoids; Tubulin Modulators; Vascular Endothelial Growth Factor A | 2006 |